BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1110 related articles for article (PubMed ID: 2435798)

  • 1. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody.
    Hathcock KS; Segal DM; Hodes RJ
    J Immunol; 1989 Apr; 142(7):2181-6. PubMed ID: 2784455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.
    Janeway CA; Haque S; Smith LA; Saizawa K
    J Mol Cell Immunol; 1987; 3(2):121-31. PubMed ID: 2978238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
    Wassmer P; Chan C; Lögdberg L; Shevach EM
    J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of L3T4+ antigen in the Con A response of regenerating splenic L3T4+ T cells after Cy treatment.
    Ikezawa Z; Sato M; Aoki I
    Immunology; 1987 Mar; 60(3):375-82. PubMed ID: 3106196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of L3T4 and Ia in the heteroclitic response of T cells to cytochrome c.
    Lakey EK; Margoliash E; Fitch FW; Pierce SK
    J Immunol; 1986 Jun; 136(11):3933-8. PubMed ID: 2422265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation requirements for normal T cells: accessory cell-dependent and -independent stimulation by anti-receptor antibodies.
    Bekoff M; Kubo R; Grey HM
    J Immunol; 1986 Sep; 137(5):1411-9. PubMed ID: 3489033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
    Jones B; Khavari PA; Conrad PJ; Janeway CA
    J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
    Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
    J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
    DeKruyff R; Clayberger C; Cantor H; Dorf ME
    J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ
    J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of valence on the functional activities of monoclonal anti-L3T4 antibodies. Discrimination of signaling from other effects.
    Haque S; Saizawa K; Rojo J; Janeway CA
    J Immunol; 1987 Nov; 139(10):3207-12. PubMed ID: 2960730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.